TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT00958633

Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder.

Cause of deathStaffing, sites or logistics, also funding or business Automatic label, confidence 0.5, unverified. How labels are made.
“Recruitment was stopped before the planned sample size was reached owing to the Covid-19 pandemic and expiration of funding.”

The sponsor’s own words in the registry.

Life of this trial

201020122014201620182020202220242026Registered2009-08-11Started2010-11Primary completion2020-03-31Stopped2020-05-20Results posted2025-05-15

Vital statistics

Status
Terminated
Phase
Phase 3
Sponsor
University of British Columbia
Sponsor type
University, hospital or other
Conditions
Bipolar I Disorder
Interventions
Escitalopram; Bupropion XL
Participants
237
Sites
1
Countries
Canada

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.